Northwest Biotherapeutics, Inc
-
Ticker
NWBO
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 11-50 Employees
- Based in Bethesda, Maryland
Northwest Biotherapeutics, Inc., a biotechnology company, discovers and develops immunotherapy products to treat cancer in the United States and internationally. It is involved in the development of DCVax, a platform technology that uses activated dendritic cells to mobilize a patient’s own immune system to attack cancer.
Northwest Biotherapeutics, Inc
Most Recent Annual Report
MOST RECENT
2019 Form 10K
Report Locked. Northwest Biotherapeutics, Inc has reached its limit for free report views.